Show simple item record

dc.contributor.authorWojtukiewicz, Marek Z
dc.contributor.authorRek, Magdalena M
dc.contributor.authorKarpowicz, Kamil
dc.contributor.authorGórska, Maria
dc.contributor.authorPolityńska, Barbara
dc.contributor.authorWojtukiewicz, Anna M
dc.contributor.authorMoniuszko, Marcin
dc.contributor.authorRadziwon, Piotr
dc.contributor.authorTucker, Stephanie C
dc.contributor.authorHonn, Kenneth V
dc.date.accessioned2021-10-29T15:35:50Z
dc.date.available2021-10-29T15:35:50Z
dc.date.issued2021-09
dc.date.submitted2021-03-26
dc.identifier.issn0167-7659
dc.identifier.others10555-021-09976-0
dc.identifier.other9976
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/330051
dc.description.abstractThe treatment of cancer patients with immune checkpoint inhibitors (ICI) (anti-CTLA-4, anti-PD-1, anti-PD-L1, combined therapy anti-PD-1/PD-L1 with anti-CTLA-4) has without doubt been a significant breakthrough in the field of oncology in recent years and constitutes a major step forward as a novel type of immunotherapy in the treatment of cancer. ICIs have contributed to a significant improvement in the outcome of treatment and prognosis of patients with different types of malignancy. With the expansion of the use of ICIs, it is expected that caregivers will face new challenges, namely, they will have to manage the adverse side effects associated with the use of these drugs. New treatment options pose new challenges not only for oncologists but also for specialists in other clinical fields, including general practitioners (GPs). They also endorse the need for taking a holistic approach to the patient, which is a principle widely recognized in oncology and especially relevant in the case of the expanding use of ICIs, which may give rise to a wide variety of organ complications resulting from treatment. Knowledge and awareness of the spectrum of immune-related adverse events (irAEs) will allow doctors to qualify patients for treatment more appropriately, prevent complications, correctly recognize, and ultimately treat them. Additionally, patients with more non-specific symptoms would be expected, in the first instance, to consult their general practitioners, as complications may appear even after the termination of treatment and do not always proceed in line with disease progression. Dealing with any iatrogenic complications, will not only be the remit of oncologists but because of the likelihood that specific organs may be affected, is likely to extend also to specialists in various fields of internal medicine. These specialists, e.g., endocrinologists, dermatologists, pulmonologists, and gastroenterologists, are likely to receive referrals for patients suffering from specific types of adverse events or will be asked to provide care in cases requiring hospitalization of patients with complications in their field of expertise. In view of these considerations, we believe that there is an urgent need for multidisciplinary teamwork in the treatment of cancer patients undergoing immunotherapy and suffering the consequent adverse reactions to treatment.
dc.languageen
dc.publisherSpringer Science and Business Media LLC
dc.subjectClinical
dc.subjectImmune checkpoint inhibitor
dc.subjectImmune-related adverse events
dc.subjectImmunotherapy
dc.subjectCTLA-4
dc.subjectPD-1
dc.subjectPD-L1
dc.titleInhibitors of immune checkpoints-PD-1, PD-L1, CTLA-4-new opportunities for cancer patients and a new challenge for internists and general practitioners.
dc.typeArticle
dc.date.updated2021-10-29T15:35:49Z
prism.endingPage982
prism.issueIdentifier3
prism.publicationNameCancer Metastasis Rev
prism.startingPage949
prism.volume40
dc.identifier.doi10.17863/CAM.77494
dcterms.dateAccepted2021-05-07
rioxxterms.versionofrecord10.1007/s10555-021-09976-0
rioxxterms.versionVoR
rioxxterms.licenseref.urihttp://creativecommons.org/licenses/by/4.0/
dc.contributor.orcidWojtukiewicz, Marek Z [0000-0002-7604-8188]
dc.identifier.eissn1573-7233
pubs.funder-project-idUniwersytet Medyczny w Bialymstoku (SUB/1/DN/21/002/1123)
cam.issuedOnline2021-07-08


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record